XML 42 R25.htm IDEA: XBRL DOCUMENT v3.23.2

Exclusive License and Option to Acquire Fortis Therapeutics (Tables)

6 Months Ended

Jun. 30, 2023

Business Combinations [Abstract]

Schedule of Allocation of Purchase Consideration Based on Estimated Fair Values of Acquired Assets

The following table represents the allocation of purchase consideration based on estimated fair values of the acquired assets (in thousands):

		Estimated Fair Value as of the Option Acquisition Date
Purchase consideration		$	—
Assets
Cash and cash equivalents			656
Prepaid expenses and other current assets			82
IPR&D assets			24,400
Total assets			25,138
Liabilities
Accounts payable			2,671
Accrued and other current liabilities			703
Total liabilities			3,374
Redeemable non-controlling interests			21,480
Nonredeemable non-controlling interests			520
Net identifiable assets, liabilities and non-controlling interests		$	(236	)
Loss on asset acquisition		$	(236	)

X

- References

No definition available.

+ Details

Name:	us-gaap_BusinessCombinationsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 50
-Paragraph 1
-URI https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472

+ Details

Name:	us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration